1.Nagarajan M, Morrell A, Fort BC, Meckley MR, Antony S, Kohlhagen G, Pommier Y, Cushman M.. (2004) Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings., 47 (23):[PMID:15509164][10.1021/jm040025z]
2.Morrell A, Jayaraman M, Nagarajan M, Fox BM, Meckley MR, Ioanoviciu A, Pommier Y, Antony S, Hollingshead M, Cushman M.. (2006) Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay., 16 (16):[PMID:16750365][10.1016/j.bmcl.2006.05.048]
3.Morrell A, Placzek MS, Steffen JD, Antony S, Agama K, Pommier Y, Cushman M.. (2007) Investigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase I inhibition and cytotoxicity in human cancer cell cultures., 50 (9):[PMID:17402722][10.1021/jm0613119]
4.Nguyen TX, Morrell A, Conda-Sheridan M, Marchand C, Agama K, Bermingham A, Stephen AG, Chergui A, Naumova A, Fisher R, O'Keefe BR, Pommier Y, Cushman M.. (2012) Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors., 55 (9):[PMID:22536944][10.1021/jm300335n]